United States · FDA National Drug Code directory
Xpect Triple Antibiotic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42961-236_a3c837b5-b59a-4853-979e-dca5ec565cf9
- Product NDC
- 42961-236
- Form
- OINTMENT
- Composition / generic term
- bacitracin zinc, neomycin sulfate, polymyxin b sulfate
- Labeler
- Cintas Corporation
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20230913
- Source listing expiry
- 20261231
Source-listed ingredients
- BACITRACIN ZINC — 400 [iU]/g
- NEOMYCIN SULFATE — 3.5 mg/g
- POLYMYXIN B SULFATE — 5000 [iU]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 10 PACKET in 1 BOX (42961-236-02) / .7 g in 1 PACKET (42961-236-01) · 42961-236-02
- 20 PACKET in 1 BOX (42961-236-03) / .7 g in 1 PACKET (42961-236-01) · 42961-236-03
- 10 PACKET in 1 BAG (42961-236-04) / .7 g in 1 PACKET (42961-236-01) · 42961-236-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →